-
1
المؤلفون: Brittany Covert Greene, Kathleen A. Neville, Djamila L. Ghafuri, Murtala Umar, Najibah A. Galadanci, Mark Rodeghier, Aisha Amal Galadanci, Jamil Galadanci, Mohammed A. Sani, Fahad M Usman, Hauwa Inuwa, Abulkadir M Tabari, Aisha Kazaure, Lawal Haliru, Safiya Gambo, Aisha A. Suleiman, Nura Idris, Adetola A. Kassim, Lori C. Jordan, Abdulrasheed Sani, Abdu Hamisu Dambatta, James C. Slaughter, Aliyu Tijjani, Charity Dooshima, Michael R. DeBaun, Fenella J. Kirkham, Awwal Gambo, Shehu U. Abdullahi, Edwin Trevathan, Muktar H. Aliyu, Aisha B. Musa, Halima Bello-Manga, Khadija Bulama, Mustapha Shuaibu Hikima, Binta W. Jibir, Gloria Bahago, Bilya Sani Musa, Awwal Musa Borodo, Jamila Sani Ibrahim
المصدر: Blood. 136:4-5
مصطلحات موضوعية: 0301 basic medicine, Relative risk reduction, medicine.medical_specialty, business.industry, Immunology, Cell Biology, Hematology, medicine.disease, Rate ratio, Biochemistry, Sickle cell anemia, law.invention, Clinical trial, 03 medical and health sciences, 030104 developmental biology, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, Clinical endpoint, Hemoglobin F, Medicine, business, Stroke, 030215 immunology
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::a3099167eeafa2e48cda10e9b95b9934
https://doi.org/10.1182/blood-2020-141436